NATCO Pharma said that it has received approval of its ANDA for Everolimus tablets for oral suspension (TFOS), a generic version of AFINITOR DISPERZ by Novartis Pharmaceutical Corporation.
Ideas corner on MSN57m
Wow! Unique ideas | amazing ideasWow! Unique ideas | amazing ideas ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback